Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

New multi-center US study finds RSV co-infection in children under two is not linked to worse clinical outcomes, challenging ...

Recent data shows that most infants are receiving RSV vaccination in the US, but rates vary by race and birth month.

In a worst-case scenario, infants can go on to develop bronchiolitis and pneumonia, with babies aged 0 to 2 months being ...

Rates of the bacterial infection have gone up by 500% since last year, with babies and young children most at risk.

The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...